Jefferies Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$11.9M Buy
230,000
+50,000
+28% +$2.97M 0.1% 162
2022
Q2
$9.46M Buy
+180,000
New +$12.5M 0.08% 203
2022
Q1
Sell
-239,900
Closed -$19.6M 1931
2021
Q4
$19.6M Buy
+239,900
New +$17.5M 0.11% 139
2021
Q2
Sell
-28,500
Closed -$1.48M 1979
2021
Q1
$1.48M Buy
+28,500
New +$1.44M 0.01% 774
2018
Q2
Sell
-67,600
Closed -$1.64M 2668
2018
Q1
$1.64M Sell
67,600
-69,200
-51% -$1.38M 0.01% 959
2017
Q4
$2.07M Buy
+136,800
New +$1.93M 0.01% 978
2015
Q4
Sell
-75,200
Closed -$2.78M 2572
2015
Q3
$2.78M Buy
75,200
+71,200
+1,780% +$3.68M 0.02% 743
2015
Q2
$232K Buy
+4,000
New +$204K ﹤0.01% 1897

Other funds holding THC

Jefferies Group's THC Position: Q3 2022 in Review

Jefferies Group increased its Tenet Healthcare (THC) stake by 156% in Q3 2022, buying an estimated $1.35M and bringing the position to 37,301 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #623.

Jefferies Group first reported a position in THC in Q3 2013 and has held it in 25 quarters since. The position peaked at $4.33M in Q3 2015. 362 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Jefferies Group held 37,301 shares of Tenet Healthcare worth $1.92M as of Q3 2022.
  • Jefferies Group bought 22,702 Tenet Healthcare shares in Q3 2022, an estimated $1.35M.
  • Tenet Healthcare made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #623 holding.
  • Jefferies Group first reported a position in Tenet Healthcare in Q3 2013 and has held it in 25 quarters since.
  • Jefferies Group's Tenet Healthcare position peaked at $4.33M in Q3 2015.
  • 362 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.